Skip to main content
Fig. 3 | Health and Quality of Life Outcomes

Fig. 3

From: Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

Fig. 3

Change from baseline in OAB-q scales and PPBC at each visit. Adjusted change from baseline generated from ANCOVA model with sequence group, study period, period-by-treatment interaction, sex and treatment as factors, baseline as covariate and subject-within-sequence as random term. a Symptom Bother; b Total HRQoL; c Coping; d Concern; e Sleep; f Social interaction; g PPBC

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us